NCT07098299 2025-11-06
Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
Barbara Ann Karmanos Cancer Institute
Phase 1 Recruiting
Clinical Trials
23 trialsNCT06130254 2025-10-14
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT06543056 2025-07-30
A Study of ES014 in Subjects With Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT05978102 2025-07-23
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 1/2 Recruiting
NCT06497010 2025-05-01
An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment
The Affiliated Hospital Of Guizhou Medical University
Phase EARLY_PHASE1 Recruiting
NCT05038150 2025-04-30
Study of SGN1 in Patients With Advanced Solid Tumor
Guangzhou Sinogen Pharmaceutical Co., Ltd
Phase 1/2 Recruiting
NCT05103345 2025-04-30
Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Guangzhou Sinogen Pharmaceutical Co., Ltd
Phase 1/2 Recruiting
NCT05916248 2025-04-01
Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT05599048 2025-03-24
Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors
University of California, San Francisco
Phase 1/2 Recruiting
NCT06173219 2025-02-27
Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.
China-Japan Friendship Hospital
Phase 1/2 Recruiting
NCT05701150 2025-02-17
CONNECT
AIO-Studien-gGmbH
Recruiting
NCT06404905 2024-12-27
BT02
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Recruiting
NCT06408688 2024-12-27
ISCA-CHECK
University Hospital, Basel, Switzerland
Phase 4 Recruiting
NCT06139211 2024-12-20
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Recruiting
NCT06084286 2024-11-19
Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients with CLDN18.2-positive Advanced Solid Tumors
Sichuan University
Phase 1 Recruiting
NCT06404281 2024-08-22
γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors
Changzhou No.2 People's Hospital
Phase 1 Recruiting
NCT06081907 2024-05-30
Promise
Hunan Province Tumor Hospital
Phase 1/2 Recruiting
NCT06037317 2024-02-02
A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Recruiting
NCT06211647 2024-01-18
A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors
Chinese PLA General Hospital
Phase 1 Recruiting
NCT06197139 2024-01-09
A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors
The First Affiliated Hospital of Guangzhou Medical University
Phase 1 Recruiting
NCT06170294 2023-12-14
MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors
Peking University
Phase 1 Recruiting
NCT06072989 2023-10-10
Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors
Shanghai East Hospital
Phase 1 Recruiting
NCT05837299 2023-05-01
A Study of IMC008 for Advanced Solid Tumors
Changhai Hospital
Phase 1 Recruiting